Plain-English translation of NCT06552637 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new device called the VisONE System that uses synchronized diaphragmatic stimulation (SDS) to help improve heart function in people with heart failure. The device is surgically implanted and works by gently stimulating the diaphragm—the main breathing muscle—in sync with your heartbeat to reduce the pressure inside your heart and improve how well it pumps. You would continue taking all your regular heart failure medications alongside this new treatment.
Heart failure causes the heart to pump less efficiently, which raises pressure inside the heart and makes it harder to exercise and feel well. Current medications help, but doctors are looking for additional ways to reduce these pressures and improve symptoms. This trial is testing whether stimulating the diaphragm at just the right moment in the heartbeat cycle could provide extra benefit.
You likely qualify if…
You likely don't qualify if…
If you qualify and enroll, you would have surgery to implant the VisONE System using a minimally invasive approach. Two weeks after implant, you would be randomly assigned to either have the device turned on (to deliver therapy) or turned off (control group) while continuing your regular heart failure medications. At 6 months, the control group's device would be turned on, so everyone would receive the active treatment by the end of the study. You would attend follow-up visits at the study center to have your symptoms, heart function, and exercise capacity checked throughout the study period.
AI-generated summary from trial data · Jun 19, 2026 · Not medical advice
United States
Sponsor
VisCardia Inc.
Collaborators
Clinical Accelerator, Duke Clinical Research Institute
Enrollment target
~270 participants
Started
April 2026
Primary completion
July 2028
Age range
18 Years and older
Last updated on clinicaltrials.gov in March 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Patricia Arand, Ph.D.
University of Pennsylvania
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.